Trump Tariffs: Will Trump impose heavy taxes on the pharma sector?

President Trump, who is aggressively moving forward with the America First slogan, does not seem to be leaving any country behind in this process. While Trump's decisions are already having a serious impact on various sectors around the world.. now he has recently made another announcement. With this, there are chances that that key sector that depends on India's exports will be seriously affected. This is already making the hearts of manufacturing and exporters in our country run wild.
Shock to many countries including India
Donald Trump, who has been targeting various countries with retaliatory taxes so far.. is now preparing to attack another new sector. He has also made a key announcement to this extent. Trump's announcement that there will be a huge tax on the pharma sector this time has now shocked many countries including India . Trump's decision is going to have a serious impact on India, which is at the top in pharma exports to the US.

Huge tariffs are going to be imposed
Recently, at an event held at the National Republican Congressional Committee, Trump said that he will soon increase huge tariffs on the pharma sector. He also revealed that this tariff will encourage pharmaceutical companies to move their operations to the US. In the past, the Trump administration had kept pharmaceuticals and semiconductors out of its retaliatory tariff policy. But now Trump has changed his mind.
Trump's latest huge shock
is actually India, the largest export market for Indian pharmaceutical products. In the last fiscal year, India exported $27.9 billion in pharma products, of which 31%, or $8.7 billion, was to the US. The US uses45 percent of generic drugsWe supply more than 15 percent of biosimilar drugs. Companies like Dr. Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, Gland Pharma earn 30-50 percent of their total revenue from the American market. Trump's latest decision is going to give them a big shock.

Impact on Indian Pharma Companies
The US market has become a major source of revenue for Indian pharmaceutical companies. Leading companies like Dr. Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, Gland Pharma earn 30-50 percent of their total revenue from the US market. Trump's new decision will be a huge economic shock to these companies. India is currently the largest exporter of pharmaceutical products to the US. In the last fiscal year, India exported pharma products worth $ 27.9 billion. Of this, 31 percent, or $ 8.7 billion, was exported to the US.

READ ALSO: Donald Trump: Trump ready for daily fines for illegal immigrants